Skip to main content

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.

Bjerke M, Portelius E, Minthon L, Wallin A, Anckarsäter H, Anckarsäter R, Andreasen N, Zetterberg H, Andreasson U, Blennow K

Publication: Int J Alzheimers Dis (2010) • Vol 2010PMID: 20798852View on PubMed

Purpose

The purpose of this paper was to determine the effects of several preanalyical and analytical factors on the measurement of the 42 amino acid form of Beta-amyloid (ABeta42) in cerebrospinal fluid (CSF).

Conclusion

ABeta42 concentrations were dependent on assay used, however, measurements were strongly correlated between assays. The use of different types of buffer other than the manufacturer provided assay buffer, different concentrations of phosphate buffered saline (PBS), and different pH values of Tris buffer had no effects on CSF ABeta42 levels. Storage of CSF in polystyrene tubes led to decreases in ABeta42 when compared to levels measured in CSF stored in polypropylene tubes. Room temperature storage for up to 24 h, freeze-thaw cycling, delayed freezing, 26 months of storage at -80 degrees C, thawing temperature, freezing method, type of freezer, storage temperature, and collection temperature had no significant influences on ABeta42 concentration. Further, aliquot sequential collection, overnight fasting, and deliberate contamination of CSF with blood had no effects on ABeta42 concentration, but dilution of CSF with serum albumin resulted in significantly decreased ABeta42 concentrations compared to undiluted CSF. A small but significant decrease in CSF ABeta42 concentration was observed in specimens collected 4-6 hours after baseline values were obtained, and CSF pH increased significantly when specimens were stored at room temperature over the course of 5 hours.

Studies (4)

Purpose

The purpose of this study was to determine the effects of method of analysis on the measurement of ABeta42 in CSF from Alzheimer's disease patients and healthy individuals.

Summary of Findings

All assays except the hAmyloid Beta42 ELISA showed significant differences in ABeta42 concentrations between Alzheimer's disease patients and healthy individuals when either CSF or CSF diluted in buffer with detergent was assayed. While absolute measurements of ABeta42 concentrations by the various assays showed large differences, correlations between all pairs of assays were strong for both diluted and undiluted CSF (0.53-0.98). The authors suggest that different sources for the ABeta42 standards used for calibration of the various assays may account for the different measurements.
  • Biospecimens

    FluidCerebrospinal Fluid
  • Preservation Types

    Frozen
  • Diagnoses

    Alzheimer's Disease
    Normal
  • Platforms

    ProteinImmunoassay
    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBiospecimen components
    CSF
    CSF diluted in buffer with detergent
    ELISA SpecificDetection method
    3D6 (amino acid 1-5)
    48G (amino acid 17-24)
    Immunoassay SpecificTechnology platform
    INNO-BIA AlzBio3
    INNO-BIA plasma ABeta forms
    INNOTEST Beta-amyloid1-42 ELISA
    MSD Abeta Triplex Ultra-Sensitive Assay
    hAmyloid Beta42 ELISA